Watch CBS News

Pfizer Faces $21 Billion in Fines for Pharmacia's Crimes; 32 Other Companies on the Hook

A jury verdict in Wisconsin could expose Pfizer to up to $21 billion in fines after the company was found guilty of gaming Medicaid. It will likely prompt a wave of settlements from other drug companies that are on the hook in this raft of cases.

Pfizer, as the successor-in-interest of its acquisition, Pharmacia, must pay only $9 million under the current decision. The case now enters a penalty phase in which the court will calculate how much to fine Pfizer for 1.4 million overcharges of Medicaid in Wisconsin. Those fines could rise to as much as $21 billion.

The case will be closely watched by dozens of other companies. The Journal-Sentinel:

Wisconsin eventually filed claims against 36 companies. Three of the companies settled for a total of $3 million. Thirty-two cases are pending, with the next one set to go to trial in December.
So there's the choice: Give Wisconsin $3 million now (or probably slightly more given the recent verdict in the state's favor) or wait, continue to pay your lawyers, and then possibly pay $21 billion -- each! -- in the future. Among the other 32 cases are Johnson & Johnson, Merck and Bristol-Myers Squibb. As the AP notes: "the lawsuit challenges the cost of "just about every significant drug out there."

My guess: Let the settlement talks begin!

Settling also keeps all those embarrasing internal memos inside their secret files. Here's the money shot from the Pharmacia case:

The Department of Justice turned up a 1993 memo from P.L. McKercher of the Upjohn Co., a predecessor company of Pharmacia, that said, "three decades of gaming of the present reimbursement scheme has provided a lucrative avenue of profit."
And another:
... the lawsuit claimed Pharmacia listed the wholesale price of its anti-breast cancer drug Adriamycin at $241.36 but actually sold the drug to providers wholesale for as low as $33.43. Pharmacia advertised the $207.93 spread to oncology providers to emphasize a wide profit margin.
If you want a primer on the vissicitudes of the average wholesale pricing system, read a digest of a ruling in a previous case, in Massachusetts, here. It's a good guide as to how these schemes work, and what the problems with the system are.

Final note: Even Pfizer's most loyal soldiers must be beginning to wish they'd never heard of Pharmacia. Pfizer acquired the company to get its Cox-2 painkiller, Celebrex ... right before the Vioxx scandal. D'oh! And the firm itself has turned out to be a nest of corruption. See a back story on its criminal human growth hormone racket here, and a primer on its formulary kickback schemes here.

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.